Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of General Virology

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/0022-1317-79-2-353PMID 9472620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.

  1996cited by this paper
• Herpes Simplex Virus Protein Targets for CD4 and CD8 Lymphocyte Cytotoxicity in Cultured Epidermal Keratinocytes Treated with Interferon-γ

  1996influential reference
• High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes

  1996cited by this paper
• Presentation of endogenous viral proteins in association with major histocompatibility complex class II: On the role of intracellular compartmentalization, invariant chain and the TAP transporter system

  1995cited by this paper
• A viral inhibitor of peptide transporters for antigen presentation

  1995influential reference
• Herpes simplex virus turns off the TAP to evade host immunity

  1995influential reference
• Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes.

  1994cited by this paper
• Herpes simplex genes: the blueprint of a successful human pathogen.

  1994cited by this paper
• Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions

  1994cited by this paper
• Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.

  1994cited by this paper
• A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

  1994influential reference
• The Proportion of Herpes Simplex Virus-Specific Cytotoxic T Lymphocytes (Tc) That Recognize Glycoprotein C Varies between Individual Mice and Is Dependent on the Form of Immunization

  1993cited by this paper
• Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus.

  1993cited by this paper
• Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

  1993cited by this paper
• Deletion of the VP16 open reading frame of herpes simplex virus type 1

  1992cited by this paper
• Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity

  1992cited by this paper
• The role of T cell immunity in control of herpes simplex virus.

  1992cited by this paper
• Pathogenesis of herpes simplex virus infection and animal models for its study.

  1992cited by this paper
• Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.

  1991cited by this paper
• Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts

  1991cited by this paper
• Critical structural elements of the VP16 transcriptional activation domain.

  1991cited by this paper
• Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.

  1989influential reference
• Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins

  1988cited by this paper
• The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

  1988cited by this paper
• Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.

  1987cited by this paper
• Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.

  1987cited by this paper
• Significance of Local γ Interferon in Recurrent Herpes Simplex Infection

  1986cited by this paper
• Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.

  1986cited by this paper
• Significance of local gamma interferon in recurrent herpes simplex infection.

  1986cited by this paper
• Recombinant Gamma Interferon Differentially Regulates Class II Antigen Expression and Biosynthesis on Cultured Normal Human Keratinocytes

  1985influential reference
• Evolution of recurrent herpes simplex lesions. An immunohistologic study.

  1985influential reference
• Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis.

  1984cited by this paper
• Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes.

  1984influential reference
• gamma Interferon production appears to predict time of recurrence of herpes labialis.

  1983cited by this paper
• Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

  1982cited by this paper
• Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis.

  1981cited by this paper
• Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions.

  1981cited by this paper
• Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response.

  1981cited by this paper
• Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes

  1980cited by this paper
• The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.

  1977cited by this paper

• Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 Infection.

  2025cites this paper
• Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology.

  2020cites this paper
• Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4+ TEM Cells in Asymptomatic Individuals and Protect from Ocular Herpes Infection and Disease in “Humanized” HLA-DR Transgenic Mice

  2020cites this paper
• Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization

  2019cites this paper
• Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design

  2019cites this paper
• Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses against Herpesvirus Infection and Disease

  2018cites this paper
• L’étude de la glycoprotéine gM du virus Herpès simplex de type 1 (HSV-l) : identification de ses partenaires viraux et cellulaires et leur rôle dans la régulation de l’infection virale

  2018cites this paper
• Dendritic cells in the cornea during Herpes simplex viral infection and inflammation.

  2017cites this paper
• Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV

  2016cites this paper
• Investigating human natural killer cell subsets and their responses to a Herpes Simplex Virus lipopeptide, a potential vaccine candidate

  2016cites this paper
• Understanding natural herpes simplex virus immunity to inform next-generation vaccine design

  2016cites this paper
• Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection

  2016influential citation
• Expression and characterization of the gD protein of HSV-2 fused to the tetramerization domain of the transcription factor p53.

  2015cites this paper
• Use of Adjuvants to Enhance the Immune Response Induced by a DNA Vaccine Against Bovine Herpesvirus-1

  2015cites this paper
• Иммунологические аспекты герпес-вирусных инфекций

  2015cites this paper
• DETECTION OF THE GLYCOPROTEIN C GENE OF CANINE HERPES VIRUS BY POLYMERASE CHAIN REACTION

  2013cites this paper
• Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults

  2013cites this paper
• Simplex Virus Glycoprotein D Lymphocyte Epitopes Identified from Herpes HLA-A*0201-Restricted CD8+ Cytotoxic T

  2013cites this paper
• Genital and Perinatal Herpes Simplex Virus Infections

  2013cites this paper
• 27 Through IFN- Simplex Virus-2 Infected Cell Proteins 4 and CD8 T Lymphocyte Cytotoxicity to Herpes Monophosphoryl Lipid A and QS21 Increase

  2013cites this paper
• Herpes Simplex Virus Antigens Directly Activate NK Cells via TLR2, Thus Facilitating Their Presentation to CD4 T Lymphocytes

  2012influential citation
• Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses

  2012cites this paper
• Control of herpes simplex virus type 1 latency in human trigeminal ganglia

  2012cites this paper
• Caractérisation de la migration du virus Herpès simplex de type 1 (HSV-1) par protéomique

  2012cites this paper
• Relation entre l’expression des LAT et du gène RL2 pendant la latence du virus HSV-1

  2012cites this paper
• MHC Class I Expression in Murine Fibroblast and Keratinocyte Cell Lines During the First Twenty- four Hours of Infection with Herpes Simplex Virus-1 (HSV-1)

  2012cites this paper
• Title Discovery of Potential Diagnostic and Vaccine Antigens in Herpes Simplex Virus 1 and 2 by Proteome-Wide Antibody Profiling Permalink

  2012influential citation
• This information is current as Lymphocytes Facilitating Their Presentation to CD 4 T Activate NK Cells via TLR 2 , Thus Herpes Simplex Virus Antigens Directly

  2012influential citation
• Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

  2012cites this paper
• Discovery of Potential Diagnostic and Vaccine Antigens in Herpes Simplex Virus 1 and 2 by Proteome-Wide Antibody Profiling

  2012influential citation
• Immunodominant “Asymptomatic” Herpes Simplex Virus 1 and 2 Protein Antigens Identified by Probing Whole-ORFome Microarrays with Serum Antibodies from Seropositive Asymptomatic versus Symptomatic Individuals

  2012cites this paper
• Host Genetic Factors in Susceptibility to Herpes Simplex Type 1 Virus Infection: Contribution of Polymorphic Genes at the Interface of Innate and Adaptive Immunity

  2012influential citation
• Control of HSV-1 latency in human trigeminal ganglia—current overview

  2011cites this paper
• Mucosal Immunity in Sexually Transmitted Infections

  2011cites this paper
• Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.

  2011cites this paper
• Increased Cell-Mediated Immune Responses in Patients with Recurrent Herpes Simplex Virus Type 2 Meningitis

  2011cites this paper
• Full length antigen priming enhances the CTL epitope-based DNA vaccine efficacy.

  2011cites this paper
• Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice

  2011cites this paper
• Étude de la sortie du virus herpès simplex de type 1 (HSV 1) hors du noyau

  2010cites this paper
• High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.

  2009influential citation
• A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

  2009cites this paper
• Induction of SOCS-1 in HSV-1-Infected Murine Keratinocytes: A Mechanism of Inhibition of Interferon Gamma

  2009influential citation
• HSV-1 and HSV-2 Seropositive Subjects Recognized by CD4 Lymphocytes from Both Simplex Virus Type 2 Glycoprotein D Are Immunodominant Epitopes in Herpes

  2008cites this paper
• Indole-3-carbinol inhibition of herpes simplex virus replication.

  2008cites this paper
• Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B

  2008cites this paper
• Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D

  2008cites this paper
• Desenvolvimento de estratégias vacinais contra tumores induzidos pelo vírus do papiloma humano tipo 16 (HPV-16) baseadas em linhagens geneticamente modificadas de Bacillus subtilis.

  2008cites this paper
• Immunodominant Epitopes in Herpes Simplex Virus Type 2 Glycoprotein D Are Recognized by CD4 Lymphocytes from Both HSV-1 and HSV-2 Seropositive Subjects1

  2008cites this paper
• HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D1

  2008cites this paper
• Simplex Virus Glycoprotein D Lymphocyte Epitopes Identified from Herpes Cytotoxic T + HLA-A*0201-Restricted CD8

  2007cites this paper
• Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans.

  2007cites this paper
• Potential prophylactic and therapeutic vaccines for HSV infections.

  2007cites this paper
• Understanding HSV‐1 entry glycoproteins

  2007cites this paper
• Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.

  2007cites this paper
• Immunology of the genital tract - a review

  2007cites this paper
• Esophageal achalasia: Is the herpes simplex virus really innocent?

  2007cites this paper
• Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection

  2006cites this paper
• Characterization of the IFN-γ T-cell responses to immediate early antigens in humans with genital herpes

  2006cites this paper
• The cycle of human herpes simplex virus infection: virus transport and immune control.

  2006cites this paper
• Genital herpes vaccines--cause for cautious optimism.

  2006cites this paper
• T cell immunity against early antigens of Human Papillomavirus type 16

  2005cites this paper
• Imunopatogeneza infekcije herpes virusom u čovjeka: implikacije za razvoj cjepiva

  2005cites this paper
• Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity.

  2005cites this paper
• Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle.

  2005influential citation
• The virus-immunity ecosystem

  2005cites this paper
• Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?

  2004influential citation
• Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge.

  2004cites this paper
• Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responses.

  2004cites this paper
• Chapter 153 – Host Defense Mechanisms Against Viruses

  2004cites this paper
• Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes.

  2003cites this paper
• Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

  2003cites this paper
• Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity

  2003influential citation
• Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice

  2003cites this paper
• Herpes Simplex Virus Type 1 Targets the MHC Class II Processing Pathway for Immune Evasion 1

  2003cites this paper
• Esophageal achalasia: Is the herpes simplex virus really innocent?

  2003cites this paper
• Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor

  2003cites this paper
• Gene regulation by tetracyclines.

  2003cites this paper
• Immune Evasion MHC Class II Processing Pathway for Herpes Simplex Virus Type 1 Targets the

  2003cites this paper
• Lawrence Corey Immunobiology and Vaccine Research Recent Progress in Herpes Simplex Virus

  2002cites this paper
• Human CD8+ CTL Recognition and In vitro Lysis of Herpes Simplex Virus‐Infected Cells by a Non‐MHC Restricted Mechanism

  2002cites this paper
• Tetracycline-dependent gene regulation: combinations of transregulators yield a variety of expression windows.

  2002cites this paper
• Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules

  2002cites this paper
• Modulation of Cellular Responses by Plasmid CD40L: CD40L Plasmid Vectors Enhance Antigen-Specific Helper T Cell Type 1 CD4+ T Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 in Vivo

  2001cites this paper
• Infected Cutaneous Cells Immediate Early Proteins and Lysis of Lesions: Recognition of Viral Tegument and CD8 CTL from Genital Herpes Simplex

  2001cites this paper
• Alpha and Gamma Interferons Inhibit Herpes Simplex Virus Type 1 Infection and Spread in Epidermal Cells after Axonal Transmission

  2001cites this paper
• A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection.

  2001cites this paper
• CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells1

  2001cites this paper
• Immune response to the herpes simplex type 1 regulatory proteins ICP8 and VP16 in infected persons

  2000cites this paper
• Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge

  2000cites this paper
• DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo

  2000cites this paper
• Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice.

  2000cites this paper
• Immune response to the herpes simplex type 1 regulatory proteins ICP8 and VP16 in infected persons.

  2000cites this paper
• Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection.

  2000cites this paper
• 8 – GENITAL AND PERINATAL HERPES SIMPLEX VIRUS INFECTIONS: PROPHYLACTIC VACCINES

  2000cites this paper
• IFN-Simplex Virus-2 Infected Cell Proteins 4 and CD 8 T Lymphocyte Cytotoxicity to Herpes Monophosphoryl Lipid A and QS 21 Increase

  2000cites this paper
• Prospects for control of herpes simplex virus disease through immunization.

  2000cites this paper
• Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex.

  2000cites this paper
• T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide

  2000cites this paper
• Monophosphoryl Lipid A and QS21 Increase CD8 T Lymphocyte Cytotoxicity to Herpes Simplex Virus-2 Infected Cell Proteins 4 and 27 Through IFN-γ and IL-12 Production1

  2000cites this paper
• Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs.

  2000cites this paper